Latest Insider Transactions at Biogen Inc. (BIIB)
This section provides a real-time view of insider transactions for Biogen Inc. (BIIB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOGEN INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOGEN INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2025
|
Stephen A Sherwin Director |
SELL
Open market or private sale
|
Direct |
8,760
-43.63%
|
$1,314,000
$150.02 P/Share
|
|
Feb 10
2025
|
Robin Kramer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
245
-2.97%
|
$34,790
$142.54 P/Share
|
|
Feb 10
2025
|
Robin Kramer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
834
+9.17%
|
-
|
|
Feb 10
2025
|
Michael R Mcdonnell EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-5.33%
|
$194,682
$142.54 P/Share
|
|
Feb 10
2025
|
Michael R Mcdonnell EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,257
+11.24%
|
-
|
|
Feb 10
2025
|
Nicole Murphy Head of Pharm Ops and Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
670
-4.55%
|
$95,140
$142.54 P/Share
|
|
Feb 10
2025
|
Nicole Murphy Head of Pharm Ops and Tech |
BUY
Exercise of conversion of derivative security
|
Direct |
2,272
+13.37%
|
-
|
|
Feb 10
2025
|
Priya Singhal Head of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-3.79%
|
$50,694
$142.54 P/Share
|
|
Feb 10
2025
|
Priya Singhal Head of Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,212
+11.4%
|
-
|
|
Feb 10
2025
|
Rachid Izzar Head of Global Product Strat. |
SELL
Payment of exercise price or tax liability
|
Direct |
445
-4.95%
|
$63,190
$142.54 P/Share
|
|
Feb 10
2025
|
Rachid Izzar Head of Global Product Strat. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,515
+14.41%
|
-
|
|
Feb 10
2025
|
Susan H Alexander EVP Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
807
-2.18%
|
$114,594
$142.54 P/Share
|
|
Feb 10
2025
|
Susan H Alexander EVP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,575
+6.49%
|
-
|
|
Feb 10
2025
|
Ginger Gregory EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
634
-3.48%
|
$90,028
$142.54 P/Share
|
|
Feb 10
2025
|
Ginger Gregory EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,159
+10.59%
|
-
|
|
Feb 07
2025
|
Rachid Izzar Head of Global Product Strat. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,844
+20.34%
|
-
|
|
Feb 07
2025
|
Rachid Izzar Head of Global Product Strat. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,165
-8.42%
|
$164,265
$141.35 P/Share
|
|
Feb 07
2025
|
Christopher Viehbacher President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,201
-20.0%
|
$451,341
$141.35 P/Share
|
|
Feb 07
2025
|
Christopher Viehbacher President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,008
+36.01%
|
-
|
|
Feb 07
2025
|
Michael R Mcdonnell EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,502
-3.35%
|
$211,782
$141.35 P/Share
|
|
Feb 07
2025
|
Michael R Mcdonnell EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,551
+9.21%
|
-
|
|
Feb 07
2025
|
Adam Keeney Head of Corporate Development |
SELL
Payment of exercise price or tax liability
|
Direct |
563
-22.86%
|
$79,383
$141.35 P/Share
|
|
Feb 07
2025
|
Adam Keeney Head of Corporate Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,801
+42.24%
|
-
|
|
Feb 07
2025
|
Jane Grogan Head of Research |
SELL
Payment of exercise price or tax liability
|
Direct |
443
-23.61%
|
$62,463
$141.35 P/Share
|
|
Feb 07
2025
|
Jane Grogan Head of Research |
BUY
Exercise of conversion of derivative security
|
Direct |
1,385
+42.47%
|
-
|
|
Feb 07
2025
|
Priya Singhal Head of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-7.66%
|
$96,021
$141.35 P/Share
|
|
Feb 07
2025
|
Priya Singhal Head of Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,216
+19.95%
|
-
|
|
Feb 07
2025
|
Nicole Murphy Head of Pharm Ops and Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-4.95%
|
$172,443
$141.35 P/Share
|
|
Feb 07
2025
|
Nicole Murphy Head of Pharm Ops and Tech |
BUY
Exercise of conversion of derivative security
|
Direct |
4,042
+14.06%
|
-
|
|
Feb 07
2025
|
Robin Kramer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
476
-3.2%
|
$67,116
$141.35 P/Share
|
|
Feb 07
2025
|
Robin Kramer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,491
+9.14%
|
-
|
|
Feb 07
2025
|
Susan H Alexander EVP Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,234
-1.79%
|
$173,994
$141.35 P/Share
|
|
Feb 07
2025
|
Susan H Alexander EVP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,130
+5.66%
|
-
|
|
Feb 07
2025
|
Ginger Gregory EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,040
-3.25%
|
$146,640
$141.35 P/Share
|
|
Feb 07
2025
|
Ginger Gregory EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
3,436
+9.71%
|
-
|
|
Jan 31
2025
|
Priya Singhal Head of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
578
-7.97%
|
$82,654
$143.93 P/Share
|
|
Jan 31
2025
|
Priya Singhal Head of Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,828
+20.13%
|
-
|
|
Dec 09
2024
|
Priya Singhal Head of Development |
SELL
Open market or private sale
|
Direct |
110
-1.99%
|
$17,270
$157.21 P/Share
|
|
Dec 06
2024
|
Robin Kramer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
170
-2.58%
|
$26,690
$157.78 P/Share
|
|
Dec 06
2024
|
Robin Kramer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
351
+5.07%
|
-
|
|
Dec 06
2024
|
Priya Singhal Head of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-3.59%
|
$32,342
$157.78 P/Share
|
|
Dec 06
2024
|
Priya Singhal Head of Development |
BUY
Exercise of conversion of derivative security
|
Direct |
426
+6.91%
|
-
|
|
Nov 05
2024
|
Susan H Alexander EVP Chief Legal Officer |
BUY
Bona fide gift
|
Indirect |
20,082
+50.0%
|
-
|
|
Nov 05
2024
|
Susan H Alexander EVP Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
20,082
-38.86%
|
-
|
|
Nov 01
2024
|
Jane Grogan Head of Research |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-29.35%
|
$35,292
$173.79 P/Share
|
|
Nov 01
2024
|
Jane Grogan Head of Research |
BUY
Exercise of conversion of derivative security
|
Direct |
695
+50.0%
|
-
|
|
Sep 03
2024
|
Priya Singhal Head of Development |
SELL
Open market or private sale
|
Direct |
431
-7.5%
|
$87,924
$204.22 P/Share
|
|
Aug 30
2024
|
Priya Singhal Head of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
807
-12.31%
|
$164,628
$204.76 P/Share
|
|
Aug 30
2024
|
Priya Singhal Head of Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,668
+20.29%
|
-
|
|
Jun 21
2024
|
Jesus B Mantas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,340
+15.35%
|
-
|